Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
An anomaly has been identified with certain aaa versions where the second source modeling for imrt fields with multiple carriage groups is incorrect. in affected aaa versions when modeling the second source the collimator jaw positions are read from the first control point of the field. this can cause an underestimation of the dose when calculating an imrt field which has multiple carriage groups. when the plan is delivered the delivered dose can be higher than planned locally by up to 10%.